Cerner (CERN) Shares Bought by Wilkins Investment Counsel Inc.

Wilkins Investment Counsel Inc. boosted its holdings in Cerner (NASDAQ:CERN) by 14.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,650 shares of the company’s stock after purchasing an additional 2,425 shares during the quarter. Wilkins Investment Counsel Inc.’s holdings in Cerner were worth $1,082,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Icon Wealth Partners LLC acquired a new position in Cerner in the fourth quarter valued at approximately $107,000. Cerebellum GP LLC acquired a new position in Cerner in the fourth quarter valued at approximately $127,000. MV Capital Management Inc. acquired a new position in Cerner in the first quarter valued at approximately $116,000. Delpha Capital Management LLC acquired a new position in Cerner in the fourth quarter valued at approximately $144,000. Finally, Virtue Capital Management LLC acquired a new position in Cerner in the fourth quarter valued at approximately $197,000. 79.92% of the stock is owned by hedge funds and other institutional investors.

Get Cerner alerts:

In other news, Vice Chairman Clifford W. Illig sold 307,700 shares of the company’s stock in a transaction that occurred on Thursday, March 8th. The stock was sold at an average price of $64.52, for a total transaction of $19,852,804.00. Following the completion of the sale, the insider now owns 1,229,719 shares in the company, valued at $79,341,469.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Clifford W. Illig sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, May 7th. The stock was sold at an average price of $58.32, for a total value of $174,960.00. Following the sale, the insider now owns 1,229,719 shares of the company’s stock, valued at approximately $71,717,212.08. The disclosure for this sale can be found here. 4.71% of the stock is owned by corporate insiders.

Cerner opened at $61.34 on Friday, MarketBeat reports. Cerner has a 12 month low of $52.05 and a 12 month high of $73.86. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.95 and a quick ratio of 2.93. The company has a market cap of $20.35 billion, a PE ratio of 27.88, a P/E/G ratio of 1.93 and a beta of 0.96.

Cerner (NASDAQ:CERN) last released its quarterly earnings results on Wednesday, May 2nd. The company reported $0.58 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.58. Cerner had a return on equity of 15.80% and a net margin of 16.50%. The business had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.34 billion. During the same quarter in the prior year, the business earned $0.59 earnings per share. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. sell-side analysts anticipate that Cerner will post 2.28 EPS for the current fiscal year.

CERN has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $80.00 price target on shares of Cerner in a report on Monday, March 5th. Wells Fargo set a $75.00 price objective on Cerner and gave the company a “buy” rating in a research note on Saturday, March 31st. Bank of America initiated coverage on Cerner in a research note on Tuesday, February 27th. They issued a “buy” rating and a $75.00 price objective for the company. Zacks Investment Research cut Cerner from a “hold” rating to a “sell” rating in a research note on Tuesday, May 8th. Finally, BidaskClub cut Cerner from a “hold” rating to a “sell” rating in a research note on Wednesday, January 24th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $68.51.

Cerner Company Profile

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner (NASDAQ:CERN).